Bulk enteric capsule shells

Abstract

The present disclosure relates to aqueous composition comprising hydroxypropyl methyl cellulose acetate succinate (HPMCAS) polymer dispersed in water, wherein the dispersed polymer is partially neutralized with at least one alkaline material. The instant disclosure also relates to compositions for use in methods of making capsule shells endowed with bulk enteric properties. The present disclosure also relates to capsules made according with the compositions and methods of the present disclosure.

Claims

1. A capsule shell made from a composition comprising: an aqueous composition comprising a dispersion of hydroxypropyl methyl cellulose acetate succinate (HPMCAS) polymer dispersed in water, wherein the polymer is present in an amount ranging from about 15% to about 25% by weight of the total weight of the aqueous composition; at least one dispersant in an amount ranging from about 0.5% to about 2% by weight of the total weight of said aqueous composition; at least one gelling agent present in an amount ranging from about 0.1% to about 5% by weight of the total weight of said aqueous composition; water; and wherein the dispersed polymer is partially neutralized with less than 0.5 w/w% of at least one alkaline material based on the total weight of the aqueous composition.

2. The capsule shell according to claim 1, further comprising at least one film forming aid in an amount ranging from about 1.6% to about 40% by weight, of the total weight of the aqueous composition.

3. The capsule shell according to claim 1, wherein the capsule shell is a hard capsule shell.

4. The capsule shell according to claim 1, wherein the amount of water, as equilibrated with the relative humidity of the outside air, ranges from about 2% to about 20% by weight of the total weight of the capsule shell.

5. The capsule shell according to claim 1, further comprising at least one encapsulated active ingredient.

6. The capsule shell according to claim 1, wherein the at least one active ingredient comprises a solid, semi-solid, or is in a liquid form.

7. The capsule shell according to claim 1, wherein the capsule exhibits a disintegration release of less than about 10% of the total encapsulated at least one active ingredient after a time of about 2 hours at a pH of about 1.2; or a dissolution release of less than about 10% of the total encapsulated at least one active ingredient after at time of about 2 hours at a pH of about 1.2.

8. The capsule shell according to claim 1, wherein the capsule exhibits a dissolution release of less than about 10% of the total encapsulated at least one active ingredient after a time of about 45 minutes in demineralized water.

9. The capsule shell according to claim 1, wherein the capsule exhibits a dissolution release of about 80% of the total encapsulated at least one active ingredient at a time of about 45 minutes at a pH of about 6.8.

10. A capsule shell comprising: hydroxypropyl methyl cellulose acetate succinate (HPMCAS) polymer, wherein the polymer is partially neutralized with 0.84 w/w% or less of at least one alkaline material based on the total weight of the capsule shell; at least one dispersant in an amount ranging from about 0.5% to about 20% by weight of the total weight of the total weight of the capsule shell; at least one thermogelling agent present in an amount ranging from about 0.1% to about 40% by weight of the total weight of the capsule shell, wherein the thermogelling agent is capable of undergoing a thermal gelation at an elevated temperature of from about 30 C. to about 80 C.; and water in an amount from about 2% wt to about 20% wt of the total weight of the capsule shell.

11. The capsule shell of claim 10, further comprising at least one film forming aid in an amount ranging up to about 40% by weight, of the total weight of the capsule shell.

12. The capsule shell of claim 10, wherein the capsule shell is a hard capsule shell.

13. The capsule shell of claim 10, wherein the amount of water, as equilibrated with the relative humidity of the outside air is less than about 10% by weight of the total weight of the capsule shell.

14. The capsule shell according to claim 10, wherein the capsule shell exhibits a disintegration release of less than about 10% of a total encapsulated at least one active ingredient after a time of about 2 hours at a pH of about 1.2.

15. The capsule shell according to claim 10, wherein the capsule shell exhibits a disintegration release of less than about 10% of a total encapsulated at least one active ingredient after at time of about 2 hours at a pH of about 1.2.

16. The capsule shell according to claim 10, wherein the capsule shell exhibits a dissolution release of less than about 10% of a total encapsulated at least one active ingredient after a time of about 45 minutes in demineralized water.

17. The capsule shell according to claim 10, wherein the capsule shell exhibits a dissolution release of about 80% of a total encapsulated at least one active ingredient at a time of about 45 minutes at a pH of about 6.8.

Description

EXAMPLES

(1) A suitable test procedure to test disintegration properties of the shells (and capsules) is as follows: USP Apparatus basket-rack assembly consisting of six open-ended transparent tubes, each tube being provided with a disk; Disintegration media: simulated gastric fluid at pH 1.2 with NaCl for 2 hours then simulated intestinal fluid at pH 6.8 with KH.sub.2PO.sub.4+NaOH; Test conditions: fluid kept at 37 C.; oscillation frequency is 30 minutes; volume of disintegration medium is 800 ml; number of samples tested is 6. Test shells #0 are pre-filled with 450 mg of acetaminophen. Capsules are placed in the tubes and a disk is over imposed. The basket is then placed in the simulated gastric fluid for 2 hours and then moved to the simulated intestinal fluid. UV (=300 nm) is used to quantify dissolved acetaminophen (as % of filled amount) in both simulated gastric and intestinal fluids.

(2) A suitable test procedure for dissolution properties of the shells (and capsules) is as follows:

(3) USP Dissolution Apparatus 2 (paddle), dissolution media: simulated gastric fluid at pH 1.2 0.1 N HCl for 2 hours then simulated intestinal fluid at pH 6.8 with Na.sub.3PO.sub.4; Test conditions: fluid kept at 37 C., paddle vessel (USP/NF) of cylindrical form with spherical end; rotation speed was 50 rpm; dissolution liquid volume is 750 ml; number of samples is 6. Test shells #0 are filled with 380 mg of acetaminophen. Capsules are then placed into the vessel which is placed in the simulated gastric fluid for 2 hours. Subsequently, 250 ml of 0.20 M tribasic sodium phosphate are added to simulated intestinal fluid pH 6.8. UV (1=300 nm) is used to quantify dissolved acetaminophen (as % of filled amount) in the dissolution media. Measures are made every 15 minutes when in the simulated gastric fluid and every 3 minutes in the simulated intestinal fluid.

(4) When tested according to USP32-NF27 monographs <701> and <711> for delayed-release dosage forms, respectively, the capsule shells once filled with acetaminophen showed at least the following profiles: Disintegration: release less than 10% of total encapsulated acetaminophen after 2 hours at pH 1.2; and Dissolution: release less than 10% of total encapsulated acetaminophen after 2 hours at pH 1.2, where 80% of the acetaminophen was released after 45 minutes at pH 6.8.

(5) A suitable test procedure for demineralised water-resistance properties of the shells (and capsules) is as follows: USP Dissolution Apparatus 2 (paddle); dissolution media: demineralised water at pH about 5.5 for 2 hours; Test conditions: fluid kept at 37 C., paddle vessel (USP/NF) of cylindrical form with spherical end; rotation speed was 50 rpm; dissolution liquid volume is 750 ml; number of samples is 6. Test shells #0 are filled with 380 mg of acetaminophen. Capsules are then placed into the vessel which is placed in the demineralised water for 1 hour. UV (A=300 nm) is used to quantify dissolved acetaminophen (as % of filled amount) in the dissolution media. Measures are made every 15 minutes. The capsule shells once filled with acetaminophen showed at least the following dissolution profiles: release less than 10% of total encapsulated acetaminophen after 2 hours in demineralised water.

(6) Description of the Test Protocols

(7) a) Determination of the Ability for the Aqueous Dispersion to Form a Continuous Film:

(8) The prepared aqueous dispersion is casted on a glass plate kept at the setting temperature of the composition using Capsugel film cast equipment (modified motorized Thin Layer Chromatography Plate Coater unit from CAMAG) or any other conventional drawdown coating equipment to make a uniform thin film having a dry thickness of about 100 m. The casted film on the glass plate is kept in an oven during 1 hour at the drying temperature, and then stored for at least 2 hours at room temperature and 50% RH to allow full drying. Once dried, the obtained film is removed from the glass plate and evaluated for visual, physical properties, and thermal properties. The Tg and the MFFT of the prepared aqueous composition are also measured with respectively DSC equipment and MFFT-bar, as per standard operating procedures for films and coating evaluation.

(9) b) Evaluation of the Aqueous Dispersion Setting Properties

(10) To reproduce the capsule dipping process, a simplified lab-scale equipment called Pin Lab Dipper has been developed to mimic the dipping of a pin into the solution. This device is equipped with an electronically-assisted module to control the pin dipping profile and withdrawal profile. It also ensures the pin rotation to the upright position and regulates the pin temperature. The dipping step is followed by a drying sequence with appropriate hot air. This test evaluates the potential setting properties of the tested solutions, whether it is possible to form a continuous and homogeneous film on the stainless steel pin by dip moulding processes.

Example 1: Preparation of an Aqueous Dispersion Comprising a Thermo-Gelling Agent

(11) The composition was made according to Table 1.

(12) TABLE-US-00001 TABLE 1 non-vol wt (g) wt % solids % Process step water 80.00 74.23 0.00 0.00 HPMCAS 20.00 18.56 18.56 78.74 Tween 80 1.20 1.11 1.11 4.72 1: dispersant NH3 0.20 0.19 0.19 0.79 2: partial neutralization water 0.37 0.34 0.00 0.00 triacetine 2.00 1.86 1.86 7.87 3: film-forming aid Poloxamer 2.00 1.86 1.86 7.87 4: thermo-gelling agent water 2.00 1.86 0.00 0.00 Total 107.77 100.00 23.57 100.00

Example 2: Preparation of an Aqueous Dispersion Comprising a Gelling Agent

(13) The composition was made according to Table 2.

(14) TABLE-US-00002 TABLE 2 non-vol wt (g) wt % solids % Process step water 80.00 64.56 0.00 0.00 HPMCAS 20.00 16.14 16.14 83.54 Tween 80 1.20 0.97 0.97 5.01 1: dispersant NH3 0.20 0.16 0.16 0.84 2: partial neutralization water 0.37 0.30 0.00 0.00 triacetine 2.00 1.61 1.61 8.35 3: film-forming aid Carrageenan 0.40 0.32 0.32 1.67 4: gelling agents Kappa KCl 0.14 0.11 0.11 0.58 water 19.60 15.82 0.00 0.00 Total 123.91 100.00 19.32 100.00

Example 3: Preparation of an Aqueous Dispersion Comprising Mixture of Alkaline Materials

(15) The composition was made according to Table 3.

(16) TABLE-US-00003 TABLE 3 non-vol wt (g) wt % solids % Process step water 80.00 73.94 0.00 0.00 HPMCAS 20.00 18.48 18.48 77.43 Tween 80 1.20 1.11 1.11 4.65 1: dispersant Eudragit E 0.43 0.40 0.40 1.66 PO NH3 0.20 0.18 0.18 0.77 2: partial neutralization water 0.37 0.34 0.00 0.00 triacetine 2.00 1.85 1.85 7.74 3: film-forming aid Poloxamer 2.00 1.85 1.85 7.74 4: thermo-gelling agent water 2.00 1.85 0.00 0.00 Total 108.20 100.00 23.87 100.00

Comparative Example 4: Preparation of a Fully Neutralised Aqueous Dispersion with Conventional Film-Forming Polymer

(17) The composition was made according to Table 4.

(18) TABLE-US-00004 TABLE 4 wt (g) wt % solids non-vol % Process step water 80.00 72.28 0.00 0.00 HPMCAS 20.00 18.07 18.07 77.76 Tween 80 1.20 1.08 1.08 4.67 1: dispersant NH3 0.52 0.47 0.47 2.02 2: full neutralization water 0.97 0.87 0.00 0.00 HPMC 4.00 3.61 3.61 15.55 3: conventional film- water 4.00 3.61 0.00 0.00 forming polymer Total 110.69 100.00 23.24 100.00

Comparative Example 5: Preparation of a Fully Neutralised Aqueous Dispersion with Conventional Film-Forming Polymer

(19) The composition was made according to Table 5.

(20) TABLE-US-00005 TABLE 5 non-vol wt (g) wt % solids % Process step water 80.00 73.61 0.00 0.00 HPMCAS 20.00 18.40 18.40 77.76 Tween 80 1.20 1.10 1.10 4.67 1: dispersant NH3 0.52 0.48 0.48 2.02 2: full neutralization water 0.97 0.89 0.00 0.00 triacetine 2.00 1.84 1.84 7.78 3: film-forming aid Poloxamer 2.00 1.84 1.84 7.78 4: thermo-gelling agent water 2.00 1.84 0.00 0.00 Total 108.69 100.00 23.66 100.00

(21) Results

(22) Table 6 provides the resulting viscosity, water resistance and flexibility results for Examples 1-5.

(23) TABLE-US-00006 TABLE 6 demineralised example # viscosity water-resistance flexibility 1 1040 cp good good 2 500 cp good fine 3 1000 cp good fine comparative 4 1200 cp poor brittle comparative 5 500 cp poor brittle
Viscosity: Measured with Brookfieldn spindle 27, 10 RPM, 21 C.
Demineralised water-resistance was determined as described previously in the test procedure. The resulting responses were rated according to the following scale as to range: poor (film dissolution below 30 minutes), medium (film dissolution between 30 minutes and 1 hour), fine (film dissolution between 1 hour and 2 hours), good (test passed, film dissolution after 2 hours). Flexibility: deformation assessment of the film. Range: poor (=brittle film), medium (=fragile film), fine (=handleable film), good (=flexible film)

(24) Additional advantages and modifications will readily occur to those skilled in the art. Therefore, the present disclosure in its broader aspects is not limited to the specific details and representative embodiments shown and described herein. Accordingly, various modifications may be made without departing from the spirit or scope of the general inventive concept as defined by the appended claims and their equivalents.